SHARPIN was previously proposed as an AD candidate gene31,32, and functional analysis of a rare missense variant (NM_030974.3:p.Gly186Arg) resulted in the aberrant cellular localization of the variant protein and attenuated the activation of NF-κB, a central mediator of inflammatory and immune responses. The gene discussed is SHARPIN; the disease is Alzheimer disease.